Live About NBT New Brunswick Today is an independent, print and digital newspaper founded in 2011. Our mission is to improve the level of civic discourse in the City of New Brunswick by accurately covering local government and demanding transparency and accountability from those in authority.
Friedreich’s ataxia is a neuromuscular condition that causes progressive loss of mobility and independence. In most cases, symptoms begin early in life, and many people with the condition begin ...
NEW BRUNSWICK, NJ—Prosecutors told a very different story in court than what they had told the press and the public about the latest murder in the streets of New Brunswick. Two local men are now incarcerated pending trial on charges they killed Gonzalo Napoleon Quispez-Parades, a 23-year-old city man who was found unconscious on a […]
NEW BRUNSWICK, NJ—Under pressure from activists, the City Council will consider a resolution regarding proposed state legislation known as the Immigrant Trust Act. The New Jersey Immigrant Trust Act (ITA) is a proposed bill that would protect immigrants by limiting the sharing of their private information by public agencies and curtailing state and local law […]
Local police investigated the shooting of an 18-year-old city resident on Harvey Street. Charlie Kratovil / New Brunswick Today NEW BRUNSWICK, NJ— City police are now investigating a trio of recent shootings, on top of one they already solved earlier in the month of September.
Live About NBT New Brunswick Today is an independent, print and digital newspaper founded in 2011. Our mission is to improve the level of civic discourse in the City of New Brunswick by accurately covering …
Local police investigated the shooting of an 18-year-old city resident on Harvey Street. Charlie Kratovil / New Brunswick Today NEW BRUNSWICK, NJ— City police are now investigating a trio …
At Burke-Tubbs Funeral Homes in Freeport, we take pride in providing a unique and welcoming environment for the families we serve throughout Stephenson County. Our facilities are thoughtfully designed to create a comforting atmosphere, featuring spacious gathering areas, natural light, and tasteful décor.
Business Insider: I'm a nanny for high-profile, high-net-worth families. Here's my advice for those who want to pursue a career like mine.
Tré Moment works as a nanny for high-profile and high-net-worth families. Moment says it's essential to set boundaries when working with affluent families. She says her career is very rewarding, but ...
I'm a nanny for high-profile, high-net-worth families. Here's my advice for those who want to pursue a career like mine.
They look drop-dead gorgeous. Funeral home to the stars Frank E. Campbell allows the families of celebrities to bring in their famous loved ones’ own makeup artists, hairdressers and stylists to make ...
Business Wire: Friedreich Ataxia Pipeline Review, H1 2016 - 13 Companies & Drug Profiles - Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Friedreich Ataxia - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information ...
Friedreich Ataxia Pipeline Review, H1 2016 - 13 Companies & Drug Profiles - Research and Markets
Please provide your email address to receive an email when new articles are posted on . Skyclarys was approved in the U.S. for Friedreich’s ataxia in 2023. Approval was based on positive results from ...
What Is Friedreich’s Ataxia? Friedreich’s ataxia is an inherited disease that affects the nervous system, especially the spinal cord, peripheral nerves, and part of the brain called the cerebellum, as ...
Precision Medicine Online: Solid Biosciences Testing Dual Delivery Gene Therapy in First-in-Human Friedreich's Ataxia Trial
Solid Biosciences Testing Dual Delivery Gene Therapy in First-in-Human Friedreich's Ataxia Trial
Please provide your email address to receive an email when new articles are posted on . Vatiquinone inhibits 15-Lipoxygenase, which regulates the pathways that Friedreich’s ataxia disrupts. PTC ...
Healthline: Help and Resources for Caregivers of Loved Ones with Friedreich’s Ataxia
BioWorld: Approved at last: Reata gets FDA handshake for Friedreich’s ataxia drug
After a long and bumpy road to approval, Reata Pharmaceuticals Inc. is to roll out the first treatment for Friedreich’s ataxia in the U.S. for patients ages 16 and older after the FDA gave its ...
Friedreich’s ataxia is a genetic condition that affects the nervous system. It’s caused by a change in a gene responsible for regulating energy production within cells. This change means that the ...
Nasdaq: Larimar Therapeutics Reports Positive Initial Data from Nomlabofusp OLE Study for Friedreich’s Ataxia
Larimar Therapeutics reports positive results from nomlabofusp study for Friedreich’s ataxia, showing increased frataxin levels and potential clinical benefits. Larimar Therapeutics announced positive ...
Larimar Therapeutics Reports Positive Initial Data from Nomlabofusp OLE Study for Friedreich’s Ataxia
It looks like Biogen Inc.’s Nrf2 activator, Skyclarys (omaveloxolone), will maintain its status as the sole therapy approved for treating patients with Friedreich’s ataxia (FA), at least for now. The ...